CD34+ stem cell top-ups without conditioning after initial haematopoietic stem cell transplantation for correction of incomplete haematopoietic and immunological recovery in severe congenital immunodeficiencies

被引:16
作者
Booth, Claire
Ribeil, Jean-Antoine
Audat, Francoise
Dal-Cortivo, Liliane
Veys, Paul A.
Thrasher, Adrian J.
Davies, E. Graham
Lefrere, Francois
Fischer, Alain
Cavazzana-Calvo, Marina
Gaspar, H. Bobby
机构
[1] UCL, Mol Immunol Unit, Inst Child Hlth, London WC1N 1EH, England
[2] Univ Paris 05, Unite Immunol & Hematol Pediat, APHP, Hop Necker, Paris 15, France
[3] Great Ormond St Hosp Sick Children, Dept Clin Immunol, London WC1N 3JH, England
[4] Univ Paris 05, APHP, Hop Necker, Dept Biotherapie, Paris 15, France
[5] Soc Francaise Greffe Moelle & Therapie Cellulaire, Paris, France
关键词
stem cell transplantation; top-up; immune reconstitution; congenital immunodeficiency;
D O I
10.1111/j.1365-2141.2006.06333.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Haematopoietic stem cell transplantation can be limited by ineffective haematopoiesis and poor immune recovery. A CD34(+) cell infusion without conditioning has the potential to improve stem cell function with limited toxicity. Eighteen patients with congenital immunodeficiencies received CD34(+) boosts for various defects. When given < 1 year after the original graft, six of seven cytopenic patients achieved transfusion independence. A second cohort (n = 11) received boosts > 1 year after the original graft; only minimal changes in immune function or chimaerism were noted. Unconditioned stem cell boosts have limited toxicity but should be given early after the original graft to be effective.
引用
收藏
页码:533 / 537
页数:5
相关论文
共 11 条
[1]   Nonmyeloablative stem cell transplantation for congenital immunodeficiencies [J].
Amrolia, P ;
Gaspar, HB ;
Hassan, A ;
Webb, D ;
Jones, A ;
Sturt, N ;
Mieli-Vergani, G ;
Pagliuca, A ;
Mufti, G ;
Hadzic, N ;
Davies, G ;
Veys, P .
BLOOD, 2000, 96 (04) :1239-1246
[2]   Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies:: report of the European experience 1968-99 [J].
Antoine, C ;
Müller, S ;
Cant, A ;
Cavazzana-Calvo, M ;
Veys, P ;
Vossen, J ;
Fasth, A ;
Heilmann, C ;
Wulffraat, N ;
Seger, R ;
Blanche, S ;
Friedrich, W ;
Abinun, M ;
Davies, G ;
Bredius, R ;
Schulz, A ;
Landais, P ;
Fischer, A .
LANCET, 2003, 361 (9357) :553-560
[3]   Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency [J].
Borghans, Jose A. ;
Bredius, Robbert G. ;
Hazenberg, Mette D. ;
Roelofs, Helene ;
Zijde, Els C. Jol-van der ;
Heidt, Jeroen ;
Otto, Sigrid A. ;
Kuijpers, Taco W. ;
Fibbe, Willem E. ;
Vossen, Jaak M. ;
Miedema, Frank ;
van Tol, Maarten J. .
BLOOD, 2006, 108 (02) :763-769
[4]   EUROPEAN EXPERIENCE OF BONE-MARROW TRANSPLANTATION FOR SEVERE COMBINED IMMUNODEFICIENCY [J].
FISCHER, A ;
LANDAIS, P ;
FRIEDRICH, W ;
MORGAN, G ;
GERRITSEN, B ;
FASTH, A ;
PORTA, F ;
GRISCELLI, C ;
GOLDMAN, SF ;
LEVINSKY, R ;
VOSSEN, J .
LANCET, 1990, 336 (8719) :850-854
[5]   Severe cutaneous papillomavirus disease after haematopoietic stem-cell transplantation in patients with severe combined immunodeficiency [J].
Gaspar, HB ;
Harwood, C ;
Leigh, I ;
Thrasher, AJ .
BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (02) :232-233
[6]   Long-term chimerism and B-cell function after bone marrow transplantation in patients with severe combined immunodeficiency with B cells: A single-center study of 22 patients [J].
Haddad, E ;
Le Deist, F ;
Aucouturier, P ;
Cavazzana-Calvo, M ;
Blanche, S ;
De Saint Basile, G ;
Fischer, A .
BLOOD, 1999, 94 (08) :2923-2930
[7]  
Haddad E, 1998, BLOOD, V91, P3646
[8]  
Kline RM, 1996, BONE MARROW TRANSPL, V17, P543
[9]   Severe cutaneous papillomavirus disease after haemopoietic stem-cell transplantation in patients with severe combined immune deficiency caused by common γc cytokine receptor subunit or JAK-3 deficiency [J].
Laffort, C ;
Le Deist, F ;
Favre, M ;
Caillat-Zucman, S ;
Radford-Weiss, I ;
Debré, M ;
Fraitag, S ;
Blanche, S ;
Cavazzana-Calvo, M ;
Saint Basile, GD ;
de Villartay, JP ;
Giliani, S ;
Orth, G ;
Casanova, JL ;
Bodemer, C ;
Fischer, A .
LANCET, 2004, 363 (9426) :2051-2054
[10]   Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation [J].
Remberger, M ;
Ringdén, O ;
Ljungman, P ;
Hägglund, H ;
Winiarski, J ;
Lönnqvist, B ;
Aschan, J .
BONE MARROW TRANSPLANTATION, 1998, 22 (01) :73-78